Five things for pharma marketers to know: Tuesday, June 11, 2019

The measles outbreak has spread to two more states: Virginia and Idaho. Authorities from the Centers for Disease Control and Prevention reported 41 new cases this week, bringing the total to 1,022 cases across the U.S. this year. (Reuters)

A look at the near death and new life of Outcome Health. MM&M senior editor Larry Dobrow interviewed Outcome Health CEO about “the most tense and scary meeting of [his] career” as he guided the company on its comeback after it was accused of misleading investors. (MM&M)

The Food and Drug Administration has given accelerated approval to a combination treatment from Roche for previously treated lymphoma patients. The drug, Polivy, is used with Rituxan and a chemotherapy agent to treat aggressive lymphoma. (Reuters)

Opioid maker Insys Therapeutics has filed for Chapter 11 bankruptcy protection. The filing came days after it agreed to pay $225 million to settle a federal investigation into the marketing practices of its painkiller fentanyl. (New York Times)

Cannabis company Green Growth Brands has struck a deal with Brookfield Properties to open 70 stores selling CBD products. The company is on track to have 280 locations in the U.S. by the end of this year. (CNBC)